Lynx patents fluid microbead DNA arrays:
This article was originally published in Clinica
Executive Summary
The US Patent Office has granted Lynx Therapeutics two patents relating to "fluid microarrays" for analysing cDNA libraries. The patents support the Hayward, California-based company's programme to develop a technology in which microbeads carrying multiple copies of DNA fragments could be an alternative to chip or surface DNA microarrays.